doi: 10.3389/fimmu.2026.1761421 Received 05 December 2025 Revised 31 January 2026 Accepted 04 February 2026 Published 24 February 2026 Volume 17 - 2026 Edited by Qiushui He, University of Turku, Finland Reviewed by Jan Josef Stepan, Charles University, Czechia Namrata Anand, University of Chicago Medical Center, United States Updates Copyright 2026 Liu, Lu, Bai, Han, Zha and Jiang
The Lexicomp and Micromedex DDI databases do not list GHK-Cu as an indexed drug, reflecting its non-approved status
Pulmonary fibrosis (PF), as the end-stage clinical phenotype of systemic sclerosis-associated interstitial lung disease (ILD), is often triggered by alveolar injury, and ferroptosis has been identified as a key aggravating factor in this disease
Wear loose, comfortable clothing with easy access to your arms